The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | H | Systemic hormonal preparations, excl. Sex hormones and insulins | |
2 | H01 | Pituitary and hypothalamic hormones and analogues | |
3 | H01B | Posterior pituitary lobe hormones | |
4 | H01BB | Oxytocin and analogues |
Code | Title | |
---|---|---|
H01BB01 | Demoxytocin | |
H01BB02 | Oxytocin | |
H01BB03 | Carbetocin |
Active Ingredient | Description | |
---|---|---|
Carbetocin |
Carbetocin selectively binds to oxytocin receptors in the smooth muscle of the uterus, stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and raises the tone of the uterus musculature. |
|
Demoxytocin |
|
|
Oxytocin |
Oxytocin is a cyclic nonapeptide that is obtained by chemical synthesis. This synthetic form is identical to the natural hormone that is stored in the posterior pituitary and released into the systemic circulation in response to suckling and labour. |
Title | Information Source | Document Type | |
---|---|---|---|
DURATOCIN Solution for injection | Health Products and Food Branch (CA) | MPI, CA: SPM | |
OFOST Solution for injection/infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
OXYTOCIN Concentrate for solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
PABAL Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
SYNTOCINON Concentrate for solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |